Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.41
+1.4%
$1.44
$0.90
$3.49
$69.51M-0.9748,288 shs12,288 shs
Biodesix, Inc. stock logo
BDSX
Biodesix
$0.42
+10.1%
$0.32
$0.17
$2.04
$56.31M0.991.11 million shs1.05 million shs
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$6.50
+5.6%
$4.24
$2.18
$9.48
$66.21M0.8356,602 shs20,745 shs
PCHM
PharmChem
$3.69
+0.3%
$3.76
$2.85
$3.98
$17.10M0.6113,943 shs2,192 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
+1.44%+10.68%+5.22%-17.30%-43.15%
Biodesix, Inc. stock logo
BDSX
Biodesix
+10.10%+8.99%+53.26%0.00%-73.06%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
+5.61%+11.79%+92.44%+179.96%+1.01%
PCHM
PharmChem
+0.27%0.00%-5.63%+23.83%+15.67%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.3525 of 5 stars
0.05.00.00.00.60.00.0
Biodesix, Inc. stock logo
BDSX
Biodesix
3.5886 of 5 stars
4.45.00.00.00.62.50.6
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
0.9001 of 5 stars
0.04.00.00.01.11.70.6
PCHM
PharmChem
0.6116 of 5 stars
0.03.00.00.00.60.81.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
Biodesix, Inc. stock logo
BDSX
Biodesix
2.80
Moderate Buy$1.75313.71% Upside
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
0.00
N/AN/AN/A
PCHM
PharmChem
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PCHM, ATPC, BNR, and BDSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/21/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Outperform ➝ Sector Outperform$3.00 ➝ $2.00
5/14/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$3.00 ➝ $2.00
5/14/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$3.00 ➝ $1.50
5/14/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$2.50 ➝ $1.50
5/14/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform
(Data available from 8/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32M53.42N/AN/A$0.48 per share2.94
Biodesix, Inc. stock logo
BDSX
Biodesix
$71.32M0.87N/AN/A$0.14 per share3.02
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$70.67M0.99N/AN/A$7.39 per share0.88
PCHM
PharmChem
$6.09M2.82N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.47M-$0.60N/AN/A-191.34%-30.95%-27.00%8/13/2025 (Estimated)
Biodesix, Inc. stock logo
BDSX
Biodesix
-$42.93M-$0.29N/AN/AN/A-54.28%-167.28%-39.96%8/7/2025 (Estimated)
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$47.49M-$1.89N/AN/A-45.41%-38.33%-25.34%8/28/2025 (Estimated)
PCHM
PharmChem
$1.38M$0.3211.53N/A24.02%N/AN/AN/A

Latest PCHM, ATPC, BNR, and BDSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Biodesix, Inc. stock logo
BDSX
Biodesix
-$0.07N/AN/AN/A$18.47 millionN/A
6/6/2025Q1 2025
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A-$0.17N/A-$0.17N/A$18.34 million
5/15/2025Q1 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.07N/A-$0.07N/AN/A
5/13/2025Q1 2025
Biodesix, Inc. stock logo
BDSX
Biodesix
-$0.08-$0.08N/A-$0.08$19.50 million$17.96 million
5/9/2025Q1 2025
PCHM
PharmChem
N/A$0.06N/A$0.06N/A$1.58 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Biodesix, Inc. stock logo
BDSX
Biodesix
N/AN/AN/AN/AN/A
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
PCHM
PharmChem
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
24.68
24.64
Biodesix, Inc. stock logo
BDSX
Biodesix
3.32
2.22
2.22
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A
3.02
2.76
PCHM
PharmChem
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
Biodesix, Inc. stock logo
BDSX
Biodesix
20.96%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.03%
PCHM
PharmChem
N/A

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
9.67%
Biodesix, Inc. stock logo
BDSX
Biodesix
30.10%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.30%
PCHM
PharmChem
17.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
4050.01 million45.17 millionNot Optionable
Biodesix, Inc. stock logo
BDSX
Biodesix
220146.56 million102.45 millionOptionable
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1,39010.76 million7.50 millionNot Optionable
PCHM
PharmChem
1704.65 million3.84 millionNot Optionable

Recent News About These Companies

PharmChem, Inc. (PCHM) - Yahoo Finance
PharmChem considers strategic alternatives
Cedar Creek Partners Q3 2024 Results
PharmChem, Inc. goes ex dividend tomorrow
Cedar Creek Partners Q2 2024 Results
Getinge AB (publ) (GTN0.F)
PharmChem, Inc. (PCHM)
Filipino Food Month in Qatar
‘Boost PHL food culture, fight food insecurity’
Punjab Chemicals and Crop Protection Ltd (PCHM)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.41 +0.02 (+1.44%)
Closing price 08/5/2025 03:59 PM Eastern
Extended Trading
$2.80 +1.39 (+98.58%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Biodesix stock logo

Biodesix NASDAQ:BDSX

$0.42 +0.04 (+10.10%)
Closing price 08/5/2025 04:00 PM Eastern
Extended Trading
$0.46 +0.04 (+9.22%)
As of 06:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$6.50 +0.35 (+5.61%)
Closing price 08/5/2025 03:58 PM Eastern
Extended Trading
$6.98 +0.49 (+7.47%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

PharmChem OTCMKTS:PCHM

$3.69 +0.01 (+0.27%)
As of 08/5/2025 03:05 PM Eastern

PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.